Sinovac Biotech (SVA) versus Alimera Sciences (ALIM) Head-To-Head Analysis

Sinovac Biotech (SVA) versus Alimera Sciences (ALIM) Head-To-Head Analysis


Sinovac Biotech and Alimera Sciences are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their analyst recommendations, earnings, valuation, risk, institutional ownership, profitabiliy and dividends. Sinovac Biotech has a beta of 0.05, meaning that its stock price is 95% less volatile than the S&P 500.



from Biotech News